Primary percutaneous coronary intervention for ST-elevation myocardial infarction: From clinical trial to clinical practice

International Journal of Cardiology

Volumn 134, Issue 1, 2009, Pages 104-109

  Rasoul, Saman ^a   Ottervanger, Jan Paul ^a   de Boer, Menko Jan ^a   Dambrink, Jan Henk E ^a   Hoorntje, Jan C A ^a   Gosselink, A T Marcel ^a   Zijlstra, Felix ^b   Suryapranata, Harry ^a   van 't Hof, Arnoud W J ^a  

^a ISALA HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Myocardial infarction; Primary PCI; STEMI

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE RECEPTOR INHIBITOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; FEMALE; HEART INFARCTION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; ST ELEVATION MYOCARDIAL INFARCTION; STENT; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NETHERLANDS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; STENTS; YOUNG ADULT;

EID: 64149097138     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.01.041     Document Type: Article

References (31)

1. Van de Werf F., Ardissino D., Betriu A., et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 24 (2003) 28-66
2. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 44 (2004) 671-719
3. Silber S., Albertsson P., Aviles F.F., et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26 (2005) 804-847
4. Rentrop P., Blanke H., Wiegand V., and Karsch K.R. Recanalization by catheter of the occluded artery after acute myocardial infarction (transluminal recanalization (author's transl)]. Dtsch Med Wochenschr 104 (1979) 1401-1405
5. Zijlstra F., de Boer M.J., Hoorntje J.C.A., et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 328 (1993) 680-684
6. Grines C.L., Browne K.F., Marco J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 328 (1993) 673-679
7. Gibbons R.J., Holmes D.R., Reeder G.S., et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med 328 (1993) 685-691
8. Montalescot G., Borentain M., Payot L., et al. Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: A meta-analysis. JAMA 292 (2004) 362-366
9. Sabatine M.S., Cannon C.P., Gibson C.M., et al. Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. JAMA 294 (2005) 1224-1232
10. Ahmad T., Webb J.G., Carere R.R., and Dodek A. Coronary stenting for acute myocardial infarction. Am J Cardiol 76 (1995) 77-80
11. Antoniucci A., Santoro G.M., Bolognese L., et al. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial. J Am Coll Cardiol 31 (1998) 1234-1239
12. Suryapranata H., van 't Hof A.W.J., Hoorntje J.C.A., et al. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 97 (1998) 2502-2505
13. Collins R., Peto R., Baigent C., and Sleight P. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med 336 (1997) 847-860
14. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 327 (1992) 669-677
15. Hennekens C., Albert C., Godfried S.L., Gazizno J.M., and Buring J.E. Adjunctive drug therapy of acute myocardial infarction evidence from clinical trials. N Engl J Med 335 (1996) 1660-1667
16. Liem A., Zijlstra F., Ottervanger J.P., et al. High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial. J Am Coll Cardiol 35 (2000) 600-604
17. De Boer M.J., Ottervanger J.P., van 't Hof A.W.J., et al. Reperfusion therapy in elderly patients with acute myocardial infarction: A randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol 39 (2002) 1723-1728
18. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
19. De Luca G., Suryapranata H., van 't Hof A.W., et al. Impact of routine stenting on myocardial perfusion and the extent of myocardial necrosis in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. Am Heart J 151 (2006) 1296.e1-6
20. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
21. Furberg C.D., Psaty B.M., and Meyer J.V. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 92 (1995) 1326-1331
22. Mandelzweig L., Battler A., Boyko V., et al. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J 27 (2006) 2285-2293
23. Dauerman H.L., Lessard D., Yarzebski J., et al. Ten-year trends in the incidence, treatment, and outcome of Q-wave myocardial infarction. Am J Cardiol 86 (2000) 730-735
24. Stenestrand U., Lindback J., and Wallentin L. RIKS-HIA Registry. Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA 296 (2006) 1749-1756
25. Fox D.J., Kibiro M., Eichhöfer J., and Curzen N.P. Postgrad Med J 81 (2005) 401-403
26. Stone G.W., Cox D., Garcia E., et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: Analysis from the primary angioplasty in myocardial infarction trials. Circulation 104 (2001) 636-641
27. De Luca G., Ernst N., Zijlstra F., et al. Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 43 (2004) 1363-1367
28. Andersen H.R., Terkelsen C.J., Thuesen L., et al. Myocardial infarction centres: The way forward. Heart 91 (2005) 12-15
29. Rogers W.J., Canto J.G., Barron H.V., Boscarino J.A., Shoultz D.A., and Every N.R. Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. Investigators in the National Registry of Myocardial Infarction. J Am Coll Cardiol 35 (2000) 371-379
30. Burwen D.R., Galusha D.H., Lewis J.M., et al. National and state trends in quality of care for acute myocardial infarction between 1994-1995 and 1998-1999: The Medicare health care quality improvement program. Arch Intern Med 163 (2003) 1430-1439
31. Angeja B.G., Gibson C.M., Chin R., et al. Predictors of door-to-balloon delay in primary angioplasty. Am J Cardiol 89 (2002) 1156-1161